THE Australian Self-Medication
Industry has reassured consumers
taking low-dose NSAIDs for short
term pain relief that the medicines
are safe when used as directed.
ASMI has issued a statement after
new research published in The
Lancet which found some NSAIDs
increased the risk of adverse events
- but those were taken at high
doses for extended periods.The above article was sent to subscribers in Pharmacy Daily's issue from 31 May 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 May 13
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.